RE:RE:RE:Adlai Nortye
Yes it makes sense as the bridging trial was already in progress and some patients had been treated with pela but now no mention of the bridging trial results which should have been done a long time ago and onc is no longer listed in their pipeline of drugs going forward as this is how it used to be mentioned so am still thinking that something has changed. I now no longer see them going forward with the phase 3 for mbc but hope I am wrong as that would also mean no royalites or milestones from this partnership.